Heart drug may unlock safe exercise for thick heart muscle patients

NCT ID NCT07077005

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 19 times

Summary

This study looks at whether the drug mavacamten can make it safe for people with a type of thickened heart muscle (hypertrophic obstructive cardiomyopathy) to do moderate exercise. About 24 adults already stable on mavacamten will either join a supervised 6-week exercise program or continue usual care. The main goal is to check safety, and researchers will also measure changes in fitness, heart function, and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY, HYPERTROPHIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Technical University Munich

    RECRUITING

    Munich, Bavaria, 81675, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.